As a watersoluble nutrient, the body typically eliminates excess B12, and there is currently no established upper intake limit for healthy individuals
Mercks Keytruda ~$25B Novo Nordisks Ozempic ~$13.9B, AbbVies Humira ~$14.4B, etc
This is because their bodies change with age
Solution: Bacteriostatic Water (0.9% Benzyl Alcohol)
not primarily appetite-driven (OUP Academic) Expected weight loss (this is where many people get misled) In major obesity trials: Semaglutide 2.4 mg weekly: ~14.9% mean weight loss at 68 weeks (STEP-1) (PubMed) Tirzepatide: ~15.0% to ~20.9% mean weight loss at 72 weeks , dose-dependent (SURMOUNT-1) (PubMed) AOD-9604s best-known human signal is kilograms, not double-digit percentages , and later studies did not sustain a strong obesity-drug profile
This totally subjective study that lacked the necessary control group(s) concluded that, in 14 of the patients, intraarticular injection of BPC-157 helps with multiple types of knee pain. In a similar 2014 study that also lacked any controls, the same group reported that BPC 157 was effective in relieving the pain associated with interstitial cystitis (bladder pain) in 10 of 12 women
